Etoricoxib hydrochlorideProduct ingredient for Etoricoxib

Name
Etoricoxib hydrochloride
Drug Entry
Etoricoxib

Etoricoxib is a new COX-2 selective inhibitor. Current therapeutic indications are: treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Like any other COX-2 selective inhibitor, Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2) to reduce the generation of prostaglandins (PGs) from arachidonic acid. It is approved in more than 60 countries worldwide but not in the US.

Accession Number
DBSALT002328
Structure
Synonyms
Not Available
UNII
138Y28RY5E
CAS Number
202409-40-3
Weight
Average: 395.3
Monoisotopic: 394.0309543
Chemical Formula
C18H16Cl2N2O2S
InChI Key
NNGHGPAKTWAHHB-UHFFFAOYSA-N
InChI
InChI=1S/C18H15ClN2O2S.ClH/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23;/h3-11H,1-2H3;1H
IUPAC Name
5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-2,3'-bipyridine hydrochloride
SMILES
Cl.CC1=CC=C(C=N1)C1=C(C=C(Cl)C=N1)C1=CC=C(C=C1)S(C)(=O)=O
ChemSpider
16345023
Predicted Properties
PropertyValueSource
Water Solubility0.00328 mg/mLALOGPS
logP3.7ALOGPS
logP2.79Chemaxon
logS-5ALOGPS
pKa (Strongest Acidic)19.69Chemaxon
pKa (Strongest Basic)4.96Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area59.92 Å2Chemaxon
Rotatable Bond Count3Chemaxon
Refractivity95.04 m3·mol-1Chemaxon
Polarizability36.43 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon